APA (7th ed.) Citation

Hargrove, D. M., Alagarsamy, S., Croston, G., Laporte, R., Qi, S., Srinivasan, K., . . . Dimitriadou, V. (2020). Pharmacological Characterization of Apraglutide, a Novel Long-Acting Peptidic Glucagon-Like Peptide-2 Agonist, for the Treatment of Short Bowel Syndrome. The Journal of pharmacology and experimental therapeutics, 373(2), 193-203. https://doi.org/10.1124/jpet.119.262238

Chicago Style (17th ed.) Citation

Hargrove, Diane M., et al. "Pharmacological Characterization of Apraglutide, a Novel Long-Acting Peptidic Glucagon-Like Peptide-2 Agonist, for the Treatment of Short Bowel Syndrome." The Journal of Pharmacology and Experimental Therapeutics 373, no. 2 (2020): 193-203. https://doi.org/10.1124/jpet.119.262238.

MLA (9th ed.) Citation

Hargrove, Diane M., et al. "Pharmacological Characterization of Apraglutide, a Novel Long-Acting Peptidic Glucagon-Like Peptide-2 Agonist, for the Treatment of Short Bowel Syndrome." The Journal of Pharmacology and Experimental Therapeutics, vol. 373, no. 2, 2020, pp. 193-203, https://doi.org/10.1124/jpet.119.262238.